Tags » Cedars-Sinai
First Patient Dosed in IST of CDK Inhibitor Seliciclib in Cushing's Disease, a Serious Endocrine Disorder
Source:Cyclacel Pharmaceuticals, Inc.
BERKELEY HEIGHTS, N.J., July 2, 2015 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders today announced that the first patient has been dosed in an investigator sponsored trial (IST) of the Company’s oral cyclin dependent kinase (CDK) inhibitor seliciclib in Cushing’s disease (CD)1. 1,065 more words
“I think it’s safe to say that we may have jerry-rigged the first effective butt vacuum. MacGyver could not have done better.”
That’s how I remember getting to know one of my regular nurses after I was first moved from the ICU of one local hospital over to the ICU at the big and impressive teaching hospital closer to the city’s center. 1,981 more words
WEST HOLLYWOOD (CBSLA.com) — The family of a West Hollywood man who was beaten by a group of men and left with a traumatic brain injury are asking the public to help identify his attackers. 256 more words
Hollywood actor, Harrison Ford crashed the single-engine World War II-era training plane that he was piloting on a golf course in Venice, California… 265 more words